"Nucleocapsid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A protein-nucleic acid complex which forms part or all of a virion. It consists of a CAPSID plus enclosed nucleic acid. Depending on the virus, the nucleocapsid may correspond to a naked core or be surrounded by a membranous envelope.
| Descriptor ID |
D019251
|
| MeSH Number(s) |
A21.249.500 B04.950.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nucleocapsid".
Below are MeSH descriptors whose meaning is more specific than "Nucleocapsid".
This graph shows the total number of publications written about "Nucleocapsid" by people in this website by year, and whether "Nucleocapsid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 3 | 3 | 6 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 4 | 1 | 5 |
| 2019 | 2 | 1 | 3 |
| 2020 | 3 | 5 | 8 |
| 2021 | 8 | 12 | 20 |
To return to the timeline, click here.
Below are the most recent publications written about "Nucleocapsid" by people in Profiles.
-
Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR. Emerg Microbes Infect. 2021 Dec; 10(1):1148-1155.
-
Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19. Clin Chem Lab Med. 2021 Nov 25; 59(12):1988-1997.
-
SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage. EMBO J. 2021 09 15; 40(18):e108249.
-
Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs. Clin Chem Lab Med. 2021 Nov 25; 59(12):2003-2009.
-
Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies. PLoS One. 2021; 16(7):e0255208.
-
SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo'. Nat Commun. 2021 07 19; 12(1):4383.
-
AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG. Int J Nanomedicine. 2021; 16:4739-4753.
-
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern. JCI Insight. 2021 07 08; 6(13).
-
Longitudinal Assessment of SARS-CoV-2 Antinucleocapsid and Antispike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection. J Appl Lab Med. 2021 07 07; 6(4):1005-1011.
-
Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results. Clin Chem. 2021 07 06; 67(7):977-986.